The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring
Abstract
OBJECTIVE: To assess the contraceptive efficacy, cycle control, tolerability, and user acceptability of a novel combined contraceptive vaginal ring for up to 13 cycles. METHODS: Healthy women requesting contraception were enrolled in this 1-year multicenter study. Each ring released 120 microg of etonogestrel and 15 microg of ethinylestradiol daily, and was used for 3 weeks followed by a 1-week ring-free period. RESULTS: A total of 2322 women started treatment and so formed the intent-to-treat population. Subjects were followed for 23,298 cycles, equivalent to 1786 woman-years. Compliance was good with 85.6% of cycles in full compliance with specified criteria. In the intent-to-treat population, 21 pregnancies occurred, giving a Pearl Index of 1.18 (95% confidence interval 0.73, 1.80). Eleven of the pregnancies were attributable to noncompliance; the Pearl Index for the per-protocol population was 0.77 (95% confidence interval 0.37, 1.40). The mean incidence of withdrawal bleeding was 98.5% in all cycles. Irregular bleeding occurred in 5.5% of all cycles, and in most women, early or late withdrawal bleeding was restricted to spotting. The ring was well tolerated with a low incidence of adverse events; only 2.5% of all discontinuations were device related. The ring was easy to insert and remove and did not interfere with intercourse. Eighty-five percent of women were satisfied with the ring, and 90% would recommend its use to others. CONCLUSION: The ring is an effective contraceptive with excellent cycle control that is convenient, well tolerated, and highly acceptable to users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition
Mulders, T. M. T., & Dieben, T. O. M. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01689-2 · Cited by 170 · cited 2×
“ethinylestradiol and 150- g desogestrel oral contraceptive.(10) In one study designed to examine the effect of”
BackgroundSelf-citationEfficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring
Weisberg, E., Fraser, I. S., Lacarra, M., Mishell, D. R., Alvarez, F., Brache, V, & Nash, H. A. (1999) · Contraception · doi:10.1016/s0010-7824(99)00035-9 · Cited by 43
Cited by
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
Curtis, K. M., Tepper, N. K., Jatlaoui, T. C., Berry-Bibee, E., Horton, L. G., Zapata, L. B., Simmons, K. B., Pagano, H. P., Jamieson, D. J., & Whiteman, M. K. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6503a1 · Cited by 1,456
The impact of medication regimen factors on adherence to chronic treatment: a review of literature
Ingersoll, K. S., & Cohen, J. (2008) · Journal of Behavioral Medicine · doi:10.1007/s10865-007-9147-y · Cited by 583
Ott, M. A., Sucato, G. S., COMMITTEE ON ADOLESCENCE, Braverman, P. K., Adelman, W. P., Alderman, E. M., Breuner, C. C., Levine, D. A., Marcell, A. V., & O’Brien, R. F. (2014) · PEDIATRICS · doi:10.1542/peds.2014-2300 · Cited by 402
COMMITTEE ON ADOLESCENCE, Braverman, P. K., Adelman, W. P., Alderman, E. M., FSHAM, Breuner, C. C., Levine, D. A., Marcell, A. V., & O’Brien, R. F. (2014) · Pediatrics · doi:10.1542/peds.2014-2299 · Cited by 355
van den Heuvel, M. W., van Bragt, A. J. M., Alnabawy, A. K. M., & Kaptein, M. C. J. (2005) · Contraception · doi:10.1016/j.contraception.2005.03.005 · Cited by 319
Metadata
- Authors
- Dieben, T.
- Venue
- Obstetrics & Gynecology
- Published
- 2002-09
- Volume
- 100
- Issue
- 3
- Pages
- 585-593
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2159074933
- Cited by
- 249
- References
- 2
- FWCI
- 15.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. https://app.cochat.ai/papers/10.1016/s0029-7844(02)02124-5
- The paper
- Dieben, T. (2002). Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstetrics & Gynecology. https://doi.org/10.1016/s0029-7844(02)02124-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.